BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2006
View Archived Issues
PD-0325901 inhibits hepatocellular carcinoma growth in vivo
Read More
GW-427353 inhibits cholinergic contraction in human colon
Read More
ZK-156979 has therapeutic effect in experimental colitis
Read More
Spectrum presents Q1 highlights
Read More
Ono updates latest developments in pipeline
Read More
Milestones in Metabolex's diabetes and obesity collaboration with Astellas
Read More
Phase IIa trial studies Phosphagenics' transdermal morphine
Read More
Orally available calpain inhibitor provides in vivo neuroprotection against retinal ischemia
Read More
BioInvent considers protocol amendment for phase I/II study of BI-201 for HIV
Read More
Canadian notice of deficiency for GlucaGen
Read More
Shire disappointed at NICE's recommendation on patients with mild Alzheimer's
Read More
PEP-005 Topical studied for cutaneous squamous cell carcinoma in situ
Read More
Herceptin plus Arimidex prolongs PFS in advanced HER2 breast cancer
Read More
Sphingosine 1-phosphate S1P1 receptor agonists emerge from Merck R&D
Read More
Bristol-Myers Squibb presents antitumor activity of new VEGFR-2 inhibitor
Read More
Pfizer present new oral PDE5 inhibitor as a candidate for male erectile dysfunction
Read More
Recent patents describe new anticoagulants
Read More
Novel alpha 1a/1d adrenoreceptor antagonists claimed for BPH treatment
Read More
Agents with potential for the treatment of metabolic disorders described in recent patents
Read More
New report from Prous Science reviews treatment options for patients with muscular dystrophy
Read More
Oracea approved for rosacea
Read More
ISTA begins pivotal studies for once-daily Xibrom
Read More
Phase II study of LE-SN-38 in metastatic colorectal cancer begins enrollment
Read More
Ortec to file HDE for cryopreserved OrCel in epidermolysis bullosa
Read More
European approval for Zostavax
Read More
Astellas returns Japanese strontium ranelate rights to Servier
Read More